GlassScriptPhysician profile
Alina Bhat
NPI 1871907147
$539.68
in general payments reported to CMS, 2019-2025
20 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $92.18 · 2021: $53.90 · 2023: $21.00 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $109 · Education: $21.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $109.46 |
| Education | $21.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intera Oncology, INC | $109.46 | 2025 | Intera |
| Ipsen Biopharmaceuticals, INC | $38.84 | 2019 | |
| Amgen INC. | $37.24 | 2019-2020 | |
| Gilead Sciences, INC. | $34.68 | 2019-2021 | |
| Janssen Biotech, INC. | $31.22 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $28.85 | 2019-2021 | |
| Astellas Pharma US INC | $27.40 | 2019 | |
| Puma Biotechnology, INC. | $26.92 | 2019 | |
| Daiichi Sankyo INC. | $24.53 | 2020 | |
| Genzyme Corporation | $24.49 | 2019-2020 | |
| Pfizer INC. | $22.32 | 2019 | |
| Merck Sharp & Dohme LLC | $22.25 | 2019-2020 | |
| Mirati Therapeutics, INC. | $21.00 | 2023 | Krazati |
| Blue Earth Diagnostics | $18.23 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.50 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $12.77 | 2020 | |
| Genentech USA, INC. | $11.92 | 2019 | |
| Taiho Oncology, INC. | $11.62 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.41 | 2019 | |
| Lilly USA, LLC | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alina Bhat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.